Icmr Clinical Trials

The ICMR successfully conducted the trial run of transporting onco-pathological samples by drones under its i-Drone initiative.

The Indian Council of Medical Research (ICMR) has completed the clinical trials of the world's first injectable male contraceptive which showed that it is safe and highly efficacious without any serious side effects.

In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.

The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.

The third phase of clinical trials for Covaxin, the coronavirus vaccine being developed by pharmaceutical firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has started. The Vice Chancellor of Aligarh Muslim University (AMU) registered as the first volunteer for the trails which will take place at the universit...

Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.

The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for COVID-19, ICMR officials said on Tuesday.

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.

A top ICMR official told a parliamentary panel on Wednesday that phase-two clinical trial of two indigenously developed COVID-19 vaccine candidates have almost been completed and emergency authorisation of a vaccine could be considered if the centre decides so.

The Phase 1 human clinical trials of two COVID-19 vaccine candidates developed indigenously by Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd have been completed and the trials have moved to Phase 2, ICMR Director General Balram Bhargava said on Tuesday.

A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.

A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.

Human clinical trials for a vaccine for COVID-19 has been initiated in the country with approximately 1,000 volunteers participating in the exercise for each of the two indigenously developed vaccine candidates, the ICMR said on Tuesday.

More than 1,100 people are expected to be enrolled in the first two phases of human clinical trials for COVAXIN - India's first COVID-19 vaccine candidate, an application by developers Bharat Biotech said Friday. Phase I clinical trials are scheduled to start next week, with July 13 set as the date for participant enrolment. Results from Phase I wi...

Adopt plasma therapy sooner for potentially complicated Covid patients and counsel survivors to donate plasma, doctors on the frontline of battle against coronavirus in Mumbai said, suggesting there needs to be a shift in use of plasma therapy to save more lives in Mumbai.

The ICMR successfully conducted the trial run of transporting onco-pathological samples by drones under its i-Drone initiative.

The Indian Council of Medical Research (ICMR) has completed the clinical trials of the world's first injectable male contraceptive which showed that it is safe and highly efficacious without any serious side effects.

In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.

The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.

The third phase of clinical trials for Covaxin, the coronavirus vaccine being developed by pharmaceutical firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has started. The Vice Chancellor of Aligarh Muslim University (AMU) registered as the first volunteer for the trails which will take place at the universit...

Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.

The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for COVID-19, ICMR officials said on Tuesday.

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.

A top ICMR official told a parliamentary panel on Wednesday that phase-two clinical trial of two indigenously developed COVID-19 vaccine candidates have almost been completed and emergency authorisation of a vaccine could be considered if the centre decides so.

The Phase 1 human clinical trials of two COVID-19 vaccine candidates developed indigenously by Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd have been completed and the trials have moved to Phase 2, ICMR Director General Balram Bhargava said on Tuesday.

A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.

A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.

Human clinical trials for a vaccine for COVID-19 has been initiated in the country with approximately 1,000 volunteers participating in the exercise for each of the two indigenously developed vaccine candidates, the ICMR said on Tuesday.

More than 1,100 people are expected to be enrolled in the first two phases of human clinical trials for COVAXIN - India's first COVID-19 vaccine candidate, an application by developers Bharat Biotech said Friday. Phase I clinical trials are scheduled to start next week, with July 13 set as the date for participant enrolment. Results from Phase I wi...

Adopt plasma therapy sooner for potentially complicated Covid patients and counsel survivors to donate plasma, doctors on the frontline of battle against coronavirus in Mumbai said, suggesting there needs to be a shift in use of plasma therapy to save more lives in Mumbai.